Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Biomedicines
|
March 29, 2023
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome
Giacomo Buso, Elisabetta Faggin, Alessandro Bressan, et al.
Molecular Biotechnology
|
April 1, 2003
Expression and characterization of biologically active human Fas ligand produced in CHO cells
Sabrina Zappitelli, Laura D'Alatri, Allesandra Ciucci, et al.
International Journal of Cancer
|
June 19, 2009
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants
Mario Bigioni, Massimo Parlani, Alessandro Bressan, et al.
International Journal of Hospitality Management
|
March 9, 2022
Overcoming the unprecedented: Micro, small and medium hospitality enterprises under COVID-19
Abel Duarte Alonso, Alessandro Bressan, Seng Kiat Kok, et al.
European Journal of Pharmacology
|
December 6, 2005
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization
Paola Cucchi, Stefania Meini, Alessandro Bressan, et al.
Bioorganic & Medicinal Chemistry
|
February 21, 2012
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine
Christopher I Fincham, Alessandro Bressan, Piero D'Andrea, et al.
Seminars in Thrombosis and Hemostasis
|
June 12, 2023
NETosis in Acute Thrombotic Disorders
Alessandro Bressan, Elisabetta Faggin, Maristella Donato, et al.
Nutrients
|
February 14, 2020
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line
Maria Giovanna Lupo, Noemi Biancorosso, Elisa Brilli, et al.
Journal of Medicinal Chemistry
|
June 9, 2006
Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides
Daniela Fattori, Cristina Rossi, Christopher I Fincham, et al.
Breast Cancer Research and Treatment
|
March 13, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Biomedicines
|
March 29, 2023
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome
Giacomo Buso, Elisabetta Faggin, Alessandro Bressan, et al.
Molecular Biotechnology
|
April 1, 2003
Expression and characterization of biologically active human Fas ligand produced in CHO cells
Sabrina Zappitelli, Laura D'Alatri, Allesandra Ciucci, et al.
International Journal of Cancer
|
June 19, 2009
Antitumor activity of delimotecan against human metastatic melanoma: pharmacokinetics and molecular determinants
Mario Bigioni, Massimo Parlani, Alessandro Bressan, et al.
International Journal of Hospitality Management
|
March 9, 2022
Overcoming the unprecedented: Micro, small and medium hospitality enterprises under COVID-19
Abel Duarte Alonso, Alessandro Bressan, Seng Kiat Kok, et al.
European Journal of Pharmacology
|
December 6, 2005
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization
Paola Cucchi, Stefania Meini, Alessandro Bressan, et al.
Bioorganic & Medicinal Chemistry
|
February 21, 2012
Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships of α,α-tetrahydropyranylglycine
Christopher I Fincham, Alessandro Bressan, Piero D'Andrea, et al.
Seminars in Thrombosis and Hemostasis
|
June 12, 2023
NETosis in Acute Thrombotic Disorders
Alessandro Bressan, Elisabetta Faggin, Maristella Donato, et al.
Nutrients
|
February 14, 2020
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line
Maria Giovanna Lupo, Noemi Biancorosso, Elisa Brilli, et al.
Journal of Medicinal Chemistry
|
June 9, 2006
Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides
Daniela Fattori, Cristina Rossi, Christopher I Fincham, et al.
Breast Cancer Research and Treatment
|
March 13, 2023
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano, et al.
Page
of 3